AR063530A1 - PROCEDURE FOR THE USE OF SODIUM ENOXAPARINE FOR THE PREPARATION OF A MEDICINAL PRODUCT - Google Patents

PROCEDURE FOR THE USE OF SODIUM ENOXAPARINE FOR THE PREPARATION OF A MEDICINAL PRODUCT

Info

Publication number
AR063530A1
AR063530A1 ARP070104788A ARP070104788A AR063530A1 AR 063530 A1 AR063530 A1 AR 063530A1 AR P070104788 A ARP070104788 A AR P070104788A AR P070104788 A ARP070104788 A AR P070104788A AR 063530 A1 AR063530 A1 AR 063530A1
Authority
AR
Argentina
Prior art keywords
sodium
patient
enoxaparine
procedure
preparation
Prior art date
Application number
ARP070104788A
Other languages
Spanish (es)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39315336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR063530(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR063530A1 publication Critical patent/AR063530A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen métodos para tratar el ictus isquémico agudo en un paciente que lo necesite, que comprende administrar al paciente una cantidad eficaz de anoxaparina sodicadurante un período de administracion terapéutico. Se describen también métodos para prevenir o tratar la trombosis, tal como los episodios tromboticos, en un paciente humano con ictus isquémico agudo, mediante el tratamiento de dicho paciente con enoxaparina.Methods for treating acute ischemic stroke in a patient in need are described, which comprises administering to the patient an effective amount of sodium anoxaparin during a period of therapeutic administration. Methods for preventing or treating thrombosis, such as thrombotic events, in a human patient with acute ischemic stroke, by treating said patient with enoxaparin are also described.

ARP070104788A 2006-10-30 2007-10-29 PROCEDURE FOR THE USE OF SODIUM ENOXAPARINE FOR THE PREPARATION OF A MEDICINAL PRODUCT AR063530A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85513706P 2006-10-30 2006-10-30

Publications (1)

Publication Number Publication Date
AR063530A1 true AR063530A1 (en) 2009-01-28

Family

ID=39315336

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070104788A AR063530A1 (en) 2006-10-30 2007-10-29 PROCEDURE FOR THE USE OF SODIUM ENOXAPARINE FOR THE PREPARATION OF A MEDICINAL PRODUCT

Country Status (4)

Country Link
AR (1) AR063530A1 (en)
CL (1) CL2007003121A1 (en)
TW (1) TW200835509A (en)
WO (1) WO2008055092A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100069326A1 (en) * 2008-02-14 2010-03-18 Wasimul Haque Combination Therapies to Treat Cardio- and Cerebro-Vascular Disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803522B1 (en) * 2000-01-06 2004-01-02 Aventis Pharma Sa NEW THERAPEUTIC APPLICATION OF ENOXAPARIN

Also Published As

Publication number Publication date
WO2008055092A3 (en) 2008-07-03
CL2007003121A1 (en) 2008-05-16
WO2008055092A2 (en) 2008-05-08
TW200835509A (en) 2008-09-01

Similar Documents

Publication Publication Date Title
CL2013000063A1 (en) A method of treating a subject comprising administering optionally deuterated n-ethyl-n-phenyl1,2-dihydroxy-4-hodroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, for the treatment of a disease autoimmune; a mixture thereof; Pharmaceutical composition and its preparation process.
ECSP12011834A (en) Pharmaceutical composition, pharmaceutical dosage form, procedure for its preparation, methods for its treatment and its uses.
EA201300121A1 (en) DPP-4 INHIBITOR IN A COMBINATION WITH AN ADDITIONAL ANTI-DIABETIC AGENT, TABLETS INCLUDING THE SPECIFIED COMPOSITIONS, THEIR APPLICATION AND METHOD OF THEIR PREPARATION
AR044007A1 (en) METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE
BR112012023021A2 (en) indazole compounds and their uses
PE20121520A1 (en) PHARMACEUTICAL FORMULATION INCLUDING RANOLAZINE AND DRONEDARONE IN THE TREATMENT OF ATRIAL FIBRILLATION
AR067903A1 (en) METHOD TO TREAT STRESSED DEPRESSION
AR049985A1 (en) COMBINATION TREATMENT FOR NON-HEMATOLOGICAL MALIGNAL DISEASES
SV2010003451A (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
UY35624A (en) USE OF HIGH DOSE PRIDOPIDINE TO TREAT HUNTINGTON'S DISEASE
BR112014006220A2 (en) galacto-ramnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic liver fat disease
DOP2011000264A (en) AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USES IN THERAPY
AR072442A1 (en) METHOD FOR CANCER THERAPY, USE, KIT
AR057946A1 (en) FORMULATION OF SUSTAINED RELEASE ZONISAMIDE
ECSP099178A (en) METHOD OF TREATMENT OF THE ICTUS WITH A THROMBOLITIC
PE20142319A1 (en) MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE
CR11418A (en) TRANS-CLOMPHENE FOR METABOLIC SYNDROME
BR112014031394A2 (en) compositions and methods for transmucosal absorption
EA201490254A1 (en) COMBINED TREATMENT OF HEPATITIS C
UY30158A1 (en) USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES FOR PAIN TREATMENT
AR074313A1 (en) METHOD TO TREAT OR PREVENT THROMBOSIS USING DABIGATRAN ETEXYLATE OR A SALT OF THE SAME. USE. KIT
UY32624A (en) PROCEDURE AND COMPOSITION TO IMPROVE THE ABSORPTION OF THERAPEUTIC AGENTS
MX2009005798A (en) Stroke recovery.
CL2011001829A1 (en) 3'-n-desmethyl-4 '' - o- (2-diethylaminoetanoyl) -6-o-methyl-9a-aza-9a-homoerythromycin a, its salts and crystalline forms 1, 2 and 3; Preparation process; use to treat inflammatory diseases; pharmaceutical composition; and composition which also comprises another active compound.
AR079000A1 (en) ANTI-BANK THERAPY AIMED AT CANCEROSA MOTHER RESISTANT DRUG CELLS

Legal Events

Date Code Title Description
FB Suspension of granting procedure